Stock Events

Stock Events

Dechra Pharmaceuticals 

$46.90
89
+$0.00+0% Wednesday 17:33

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
5.34B
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 26
$0.41
May 26
$0.41
Feb 26
$0.41
Nov 25
$0.41
Aug 25
$0.41
10Y Growth
20.14%
5Y Growth
0.32%
3Y Growth
-2.34%
1Y Growth
-3.49%

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
0
0.07
0.14
0.2
Expected EPS
0
Actual EPS
0.2046

Financials

8.73%Profit Margin
Profitable
2017
2018
2019
2020
2021
2022
874.75MRevenue
76.36MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regency Centers
REG
Mkt Cap13.78B
Regency Centers Corporation specializes in shopping centers, directly competing with Cedar Realty's focus on retail properties.
Federal Realty Investment Trust.
FRT
Mkt Cap10.17B
Federal Realty Investment Trust is known for its high-quality retail and mixed-use properties, making it a direct competitor in the retail space.
Kimco Realty
KIM
Mkt Cap15.83B
Kimco Realty Corporation is one of the largest publicly traded owners and operators of open-air shopping centers, a direct competitor to Cedar's retail focus.
Brixmor Property Group
BRX
Mkt Cap8.95B
Brixmor Property Group operates a national portfolio of open-air shopping centers, positioning it as a competitor in the retail real estate market.
SITE Centers
SITC
Mkt Cap150.6M
SITE Centers is a real estate investment trust that focuses on shopping centers, making it a competitor in the retail property sector.
Urban Edge Properties
UE
Mkt Cap2.65B
Urban Edge Properties, a real estate company focusing on retail properties in urban communities, competes with Cedar Realty in the retail market.
Acadia Realty Trust
AKR
Mkt Cap2.79B
Acadia Realty Trust is focused on the acquisition, development, and management of retail properties, competing with Cedar Realty in the retail real estate sector.

About

Pharmaceuticals: Other
Health Technology
Cedar Realty Trust, Inc. is a real estate investment trust that focuses on owning and operating income-producing retail properties with a primary focus on grocery-anchored shopping centers, predominantly located in the Northeast. It is a wholly owned subsidiary of Wheeler Real Estate Investment Trust.
Show more...
CEO
Michael Andrew Franklin
Employees
55
Country
United States
ISIN
GB0009633180
WKN
000578968

Listings

XNYS
US
CDR-PB
XNYS
US
CDR-PC
STU
DE
1PK.STU
F
DE
1PK.F

0 Comments

Share your thoughts

FAQ

What is Dechra Pharmaceuticals stock price today?▼
The current price of DCHPF is $46.90 USD — it has increased by +0% in the past 24 hours. Watch Dechra Pharmaceuticals stock price performance more closely on the chart.
What is Dechra Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Dechra Pharmaceuticals stocks are traded under the ticker DCHPF.
What is Dechra Pharmaceuticals market cap?▼
Today Dechra Pharmaceuticals has the market capitalization of 5.34B
What were Dechra Pharmaceuticals earnings last quarter?▼
DCHPF earnings for the last quarter are 0.2 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dechra Pharmaceuticals revenue for the last year?▼
Dechra Pharmaceuticals revenue for the last year amounts to 874.75M USD.
What is Dechra Pharmaceuticals net income for the last year?▼
DCHPF net income for the last year is 76.36M USD.
Does Dechra Pharmaceuticals pay dividends?▼
Yes, DCHPF dividends are paid semi-annual. The last dividend per share was 0.38 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Dechra Pharmaceuticals have?▼
As of September 08, 2026, the company has 55 employees.
In which sector is Dechra Pharmaceuticals located?▼
Dechra Pharmaceuticals operates in the Real Estate sector.
When did Dechra Pharmaceuticals complete a stock split?▼
Dechra Pharmaceuticals has not had any recent stock splits.
Where is Dechra Pharmaceuticals headquartered?▼
Dechra Pharmaceuticals is headquartered in Virginia Beach, United States.